HIV cure research developments are growing and evolving at a stead pace, as evidenced by the number of planned and ongoing HIV cure trials testing broadly neutralizing antibodies (bNAbs) or combinations of bNAbs with other interventions. In this webinar leading expert Marina Caskey of Rockefeller University, will discuss how bNAbs have the potential to advance the HIV cure agenda. She will provide an overview of the science as well as discuss her experience leading clinical studies evaluating bNAbs for an HIV cure and treatment. Philister Adhiambo Madiega, an HIV cure advocate and community engagement manager at the Kenya Medical Research Institute, will share strategies on how to initiate and sustain stakeholder engagement in HIV cure research.
View the webinar here:https://www.youtube.com/watch?v=ePkgGi2gegw